Navigation Links
MedImmune Announces Positive Clinical Results at PAS Annual Meeting,From Large Prospective Trial in Prevention of Serious RSV Disease

eas of pediatric infectious diseases, cancer and inflammatory diseases. With more than 2,500 employees worldwide, MedImmune is headquartered in Maryland. For more information, visit the company's website at www.medimmune.com.

Forward Looking Statements

This announcement may contain, in addition to historical information, certain forward-looking statements regarding motavizumab, an investigational MAb, which involve risks and uncertainties. Such statements reflect management's current views and are based on certain assumptions. Actual results could differ materially from those currently anticipated as a result of a number of factors, including risks and uncertainties discussed in MedImmune's filings with the U.S. Securities and Exchange Commission. The company is developing motavizumab for potential future marketing. There can be no assurance that such development efforts will succeed, that motavizumab will receive required regulatory approval or that, even if such regulatory approval is received, that motavizumab would ultimately achieve commercial success.

Notice to Investors and Stockholders of MedImmune

This release is neither an offer to purchase nor a solicitation of an offer to sell shares of MedImmune. MedImmune stockholders are urged to read the relevant tender offer documents from AstraZeneca PLC which have been filed on May 3, 2007 because they will contain important information that stockholders should consider before making any decision regarding tendering their shares. AstraZeneca has filed tender offer materials with the U.S. Securities and Exchange Commission, and MedImmune has also filed a Solicitation/Recommendation Statement on Schedule 14D-9 with respect to the offer. The tender offer materials (including an Offer to Purchase, a related Letter of Transmittal and certain other offer documents) and the Solicitation/Recommendation Statement contain important informat
'"/>




Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Infinity and MedImmune Present Updated Phase I Results of IPI-504 in GIST at ASCO Annual Meeting
2. Infinity and MedImmune Announce Updated Data On Ipi-504 to be Presented At ASCO
3. MedImmune Highlights Advances in Inflammatory Disease Pipeline With Series of Data Presentations
4. Pediatric Academic Societies Annual Meeting to Feature Data Presentations Related to MedImmune Clinical Programs in Influenza, RSV and hMPV
5. Micromet Achieves Milestone in BiTE Research Collaboration with MedImmune
6. MedImmune Publishes New Data in Nature Immunology Demonstrating The Role HMGB1 May Play in Systemic Autoimmune Diseases
7. MedImmune and Micromet Publish Data on Novel Anti-Cancer BiTE Molecule
8. Micromet and MedImmune Present Data From Preclinical Study of New BiTE Molecule Targeting CEA
9. Infinity and MedImmune to Present Preclinical Data From Study of Oral Formulation of IPI-504 At AACR
10. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
11. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
Post Your Comments:
(Date:1/15/2014)... Jan. 15, 2014  Echo Therapeutics, Inc. (Nasdaq: ... company developing its Symphony® CGM System as a ... that Robert F. Doman , Executive Chairman ... at "TEN", Noble Financial Capital Markets, Tenth Annual ... make a corporate presentation to prospective corporate partners ...
(Date:1/15/2014)... Quebec , Jan. 15, 2014  Valeant Pharmaceuticals ... VRX) announced that the applicable waiting period under the ... to the previously announced tender offer by its indirect ... the outstanding shares of common stock of Solta Medical, ... price of $2.92 per share, net to the seller ...
(Date:1/14/2014)... 14, 2014 HeartWare International, Inc ... innovator of less invasive, miniaturized circulatory support technologies ... failure, today announced that it expects revenues for ... $53 million, bringing expected full-year 2013 revenues to ... growth of 87% for 2013 above 2012 reflects ...
Breaking Medicine Technology:Echo Therapeutics to Present at the Noble Financial Capital Markets' Tenth Annual Equity Conference 2Echo Therapeutics to Present at the Noble Financial Capital Markets' Tenth Annual Equity Conference 3Valeant Pharmaceuticals Announces Receipt Of Antitrust Clearance For Its Previously Announced Acquisition Of Solta Medical, Inc. 2Valeant Pharmaceuticals Announces Receipt Of Antitrust Clearance For Its Previously Announced Acquisition Of Solta Medical, Inc. 3HeartWare International Announces Preliminary Fourth Quarter 2013 Revenues 2HeartWare International Announces Preliminary Fourth Quarter 2013 Revenues 3HeartWare International Announces Preliminary Fourth Quarter 2013 Revenues 4
... Netherlands, SHENZHEN, China and HUIZHOU, China, Dec. 15, 2010 ... a new disposable wireless diagnostic test platform for consumer ... for pregnancy, fertility, pathogens, AIDS, drugs, allergens and even ... will enable much more rapid diagnoses for diseases and ...
... Inc. (Nasdaq: BNVI ) today announced the publication ... cells to glucose limitation" in the journal Cell Cycle ... of the protein CC3/TIP30 in cancer cells and their ability ... of glucose and other nutrients. Lack of CC3/TIP30 in a ...
Cached Medicine Technology:Cell Phones Are Now Personal Diagnostic Tools That Can Monitor Fertility, Pathogens, AIDS, Drugs, and Allergens 2Bionovo Announces Publication Describing How Metabolic Adaptability Contributes to the Metastasis of Tumors 2Bionovo Announces Publication Describing How Metabolic Adaptability Contributes to the Metastasis of Tumors 3
(Date:4/15/2014)... the United States have nearly doubled since 1988, suggests ... Public Health, with obesity apparently to blame for the ... the disease has not hit all groups equally, with ... elderly. , According to new research reported in the ... Internal Medicine , diabetes increased from 6 percent to ...
(Date:4/15/2014)... decades-old medical mystery and in the process have found ... which kill about 1.5 million people a year. The researchers ... an antifungal drug that has been in use for more ... toxic to human cells as it is to the microbes ... findings appears in Nature Chemical Biology . , "Invasive ...
(Date:4/15/2014)... Diego School of Medicine have identified a mechanism that ... liver disease and why the virus is able to ... The hard-to-kill pathogen, which infects an estimated 200 million ... the mitochondria dismantling the cell,s innate ability to ... dynamics. , The study, published in today,s issue of ...
(Date:4/14/2014)... children orphaned by HIV/AIDS in South Africa may provide ... emotional behavior issues in other areas of the world, ... research that could lead to successful interventions. , ... the United Nations mentions that due to the HIV/AIDS ... Sub-Saharan African, children are at an increased risk for ...
(Date:4/14/2014)... International and American Associations for Dental Research (IADR/AADR) ... and Their Dental, Oral, and Craniofacial Manifestations." The ... B. Burke, Alison M. Boyce, Michael Collins, Brian ... Mary Scott Ramnitz, Martha J. Somerman and J. ... of the IADR/AADR Journal of Dental Research ...
Breaking Medicine News(10 mins):Health News:Pre-diabetes and diabetes nearly double over the past 2 decades 2Health News:Potent, puzzling and (now less) toxic: Team discovers how antifungal drug works 2Health News:Potent, puzzling and (now less) toxic: Team discovers how antifungal drug works 3Health News:Breaking bad mitochondria 2Health News:Researchers identify children with emotional behavior difficulties 2Health News:Researchers identify children with emotional behavior difficulties 3Health News:Rare bone diseases and their dental, oral and craniofacial manifestations 2
... Ontario (CHEO )researcher has found that children and babies are ... fact that generation subsists on cod liver oil, ... has persisted in too many children in Canada. ... stunts growth, the disease can cause painful bone deformities. Very ...
... has shown that regular vaccination of infants against H. ... Hib pneumonia and meningitis, could save innumerable children in ... is published online in The Pediatric Infectious Disease Journal, ... Hib conjugate vaccine prevented more than one-third of acute ...
... focused on cognitive skills may improve child behaviour. ... of the New York Academy of Sciences children who ... consideration of their own and others' emotions were found ... emotional problems. ,The study showed that ...
... to afflict humans very early, not sparing even tiny tots. Children ... in New South Wales in Australia. ,Anxiety disorders ... Macquarie University's Anxiety Research Unit show. ,In children aged ... compared to a rate of about 1 per cent for mood ...
... one bacterial species into another by swapping their genomes, a ... bugs, a pioneer on genetics said Thursday. ... genome, said a team of his researchers had transplanted the ... related species. ,The experiment marks the most ambitious ...
... in movie 'Hairspray', is happy the female costumes he wore helped ... having to wear a fat suit, dress, and high heels to ... iconic musical-turned-movie was the perfect combination to shed the pounds. ... of weight to carry around," Contactmusic quotes him as saying. ...
Cached Medicine News:Health News:Vitamin D Deficiency Still Persists in Babies 2Health News:Routine Hib Vaccination Could Save Innumerable Asian Children 2Health News:Routine Hib Vaccination Could Save Innumerable Asian Children 3Health News:Cognitive Skills Focused Curriculum may Lessen Kids' Behavioural Problems 2Health News:Anxiety Disorders Show in Tiny Tots 2Health News:Replacing a Genome Boosts Race to Develop Designer Bugs: Study 2Health News:Replacing a Genome Boosts Race to Develop Designer Bugs: Study 3
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: